St Thomas' Hospital is a large NHS teaching hospital in Central London, England. It is one of the institutions that compose the King's Health Partners, an academic health science centre.

There are 840 beds in Guy's and St Thomas' NHS Foundation Trust.

During the past decade, Guy's and St Thomas' NHS Foundation Trust conducted 662 clinical trials. In the 10-year time frame, 662 clinical trials started and 173 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 263 clinical trials started and 126 clinical trials were completed. i.e. 47.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guy's and St Thomas' NHS Foundation Trust" #1 sponsor was "Guy's and St Thomas' NHS Foundation Trust" with 147 trials, followed by "King's College London" with 38 trials sponsored, "University College, London" with 36 trials sponsored, "Hoffmann-La Roche" with 28 trials sponsored and "Pfizer" with 28 trials sponsored. Other sponsors include 662 different institutions and companies that sponsored additional 348 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guy's and St Thomas' NHS Foundation Trust" #1 collaborator was "King's College London" with 57 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 39 trials as a collaborator, "Cancer Research UK" with 32 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 19 trials as a collaborator and "AstraZeneca" with 17 trials as a collaborator. Other collaborators include 962 different institutions and companies that were collaborators in the rest 625 trials.

According to Clinical.Site data, the most researched conditions in "Guy's and St Thomas' NHS Foundation Trust" are "Breast Cancer" (30 trials), "Prostate Cancer" (21 trials), "Heart Failure" (19 trials), "Ulcerative Colitis" (18 trials) and "Sickle Cell Disease" (15 trials). Many other conditions were trialed in "Guy's and St Thomas' NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Guy's and St Thomas' NHS Foundation Trust" are "Drug" (497 trials), "Other" (145 trials), "Device" (133 trials), "Procedure" (76 trials) and "Biological" (67 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (118 trials), "Atezolizumab" (12 trials), "Cisplatin" (12 trials), "Paclitaxel" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Guy's and St Thomas' NHS Foundation Trust" are 815 trials for "All" genders, 77 trials for "Female" genders and 47 trials for "Male" genders.

Currently, there are 315 active trials in "Guy's and St Thomas' NHS Foundation Trust". 14 are not yet recruiting, 181 are recruiting, 118 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 425 completed trials in Guy's and St Thomas' NHS Foundation Trust, 5 suspended trials, and 70 terminated clinical trials to date.

Out of the total trials that were conducted in Guy's and St Thomas' NHS Foundation Trust, 90 "Phase 1" clinical trials were conducted, 220 "Phase 2" clinical trials and 276 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 41 trials, and there were also 187 trials that are defined as “Not Applicable".

Guy's and St Thomas' NHS Foundation Trust has several departments that took part in Clinical trials: "Guys & St Thomas Hospital; Department of Oncology" - 7 trials, "Cancer Research UK Clinical Groups at Guy's King's & St. Thomas' Hospitals" - 5 trials, "Guy's Hospital; Louise Coote Lupus Unit" - 3 trials, "Oesophageal Laboratory, GSTT" - 3 trials, "Guy's & St. Thomas Cancer Centre" - 2 trials, "Dental Institute, Guy's Hospital" - 2 trials, "Neurofibromatosis Unit, Guys Hospital." - 2 trials, "St John's Institute Of Dermatology - Guy's & St Thomas' Nhs Foundation Trust" - 2 trials